bm41
Allergenexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 17, 2018 (NCT04912076)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, desensitized
Immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04912076 | Phase 1 | Sep 17, 2018 | Biomay AG, European Commission, University of Amsterdam, University of Salzburg, University of Southern Denmark |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomay AG | For profit | 1 | 0 | 1 | 2018 |
| European Commission | Government | 1 | 0 | 1 | 2018 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Salzburg | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Southern Denmark | Academic/Hospital | 1 | 1 | 1 | 2018 |
5 organizations
Page 1 / 1